ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.793,27
2,38%
Brent Oil
83,76
0,67%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Theratechnologies Inc (TH)

  7. Theratechnologies Inc (TH) Notícias

TH

Theratechnologies (TH)

Theratechnologies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:TH
DataHoraFonteTítuloCódigoCompanhia
02/01/202411:00AllPennyStocks.comWill This Dual-Listed Bio-Pharma Catch New Year Action?TSX:THTheratechnologies Inc
21/12/202318:12PR Newswire (Canada)Theratechnologies annonce le renouvellement de son prospectus préalable et le dépôt de sa déclaration d'inscriptionTSX:THTheratechnologies Inc
21/12/202318:09PR Newswire (US)Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration StatementTSX:THTheratechnologies Inc
21/08/202316:24PR Newswire (Canada)Toronto Stock Exchange, Theratechnologies Inc., View From The C-SuiteTSX:THTheratechnologies Inc
31/07/202310:00AllPennyStocks.comBiopharma Firm Completes Reverse Stock SplitTSX:THTheratechnologies Inc
19/05/202318:11PR Newswire (Canada)Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc.TSX:THTheratechnologies Inc
27/04/202208:30PR Newswire (US)THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORYTSX:THTheratechnologies Inc
27/04/202208:30PR Newswire (Canada)THERATECHNOLOGIES ANNONCE SON INTENTION DE CONCENTRER SES ACTIVITÉS DE COMMERCIALISATION SUR LE TERRITOIRE NORD-AMÉRICAINTSX:THTheratechnologies Inc
23/11/202111:48PR Newswire (Canada)Theratechnologies annonce le renouvellement de son prospectus préalable et de sa déclaration d'inscription; le programme de placements d'actions au cours du marché sera prolongéTSX:THTheratechnologies Inc
23/11/202111:46PR Newswire (Canada)Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be ExtendedTSX:THTheratechnologies Inc
23/07/202120:36PR Newswire (Canada)Theratechnologies établit un programme de placements d'actions au cours du marchéTSX:THTheratechnologies Inc
23/07/202120:30PR Newswire (Canada)Theratechnologies Establishes New At-The-Market FacilityTSX:THTheratechnologies Inc
10/09/202011:08PR Newswire (US)Theratechnologies Announces Launch of Trogarzo® in GermanyTSX:THTheratechnologies Inc
02/03/202010:00PR Newswire (Canada)Changement à la direction de TheratechnologiesTSX:THTheratechnologies Inc
02/03/202010:00PR Newswire (Canada)Change to Theratechnologies ManagementTSX:THTheratechnologies Inc
26/09/201910:00PR Newswire (Canada)Toronto Stock Exchange Introduces the TSX30TSX:THTheratechnologies Inc
26/09/201910:00PR Newswire (Canada)La Bourse de Toronto lance le palmarès TSX 30TSX:THTheratechnologies Inc
25/02/201912:10PR Newswire (Canada)Aligo Innovation annonce l'acquisition par Theratechnologies de Katana Biopharma Inc, une compagnie de biotechnologie pour le...TSX:THTheratechnologies Inc
06/03/201817:32PR Newswire (US)Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 In...TSX:THTheratechnologies Inc
06/03/201817:13PR Newswire (Canada)Theratechnologies annonce l'approbation par la FDA de la percée thérapeutique Trogarzo(MC) (ibalizumab-uiyk) injection, le ...TSX:THTheratechnologies Inc
06/03/201816:35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - THTSX:THTheratechnologies Inc
06/03/201816:33PR Newswire (Canada)IIROC Trade Resumption - THTSX:THTheratechnologies Inc
06/03/201814:53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - THTSX:THTheratechnologies Inc
06/03/201814:52PR Newswire (Canada)IIROC Trading Halt - THTSX:THTheratechnologies Inc
04/10/201708:00PR Newswire (US)Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™TSX:THTheratechnologies Inc
24/07/201708:30PR Newswire (US)Theratechnologies Announces New Findings with the Investigational Antiretroviral Ibalizumab and with EGRIFTA® (tesamorelin f...TSX:THTheratechnologies Inc
16/05/201714:52PR Newswire (Canada)Les actionnaires élisent une nouvelle membre du Conseil au cours de l'assemblée annuelle de TheratechnologiesTSX:THTheratechnologies Inc
16/05/201714:14PR Newswire (Canada)Shareholders elect new Board member during Theratechnologies' annual meetingTSX:THTheratechnologies Inc
16/05/201713:32PR Newswire (Canada)Annonces en marge de l'assemblée annuelle de TheratechnologiesTSX:THTheratechnologies Inc
16/05/201713:27PR Newswire (Canada)Announcements in conjunction with Theratechnologies annual meetingTSX:THTheratechnologies Inc
 Apresentando as notícias mais relevantes sobre:TSX:TH

Seu Histórico Recente

NASDAQ
AAZPXXX
Credit Suisse Ag London ...
GATE
MDSETH
MediShares
EU
INCN1
Casam Etf CN1 Inav
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados